The ratio of the concentration of RANKL to that of osteoprotegerin is also upregulated in the synovial fluid of patients with RA compared to that in the synovial fluid of patients administered oroxylin A or with gout. The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.